CompletedInterventionalPhase 2Last updated Mar 20, 2009

An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee

A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Doses of IDEA-033 in Comparison to Oral Naproxen for the Treatment of the Signs and Symptoms of Osteoarthritis of the Knee

Overview

ClinicalTrials.gov ID: NCT00211549
Lead Sponsor: IDEA AGINDUSTRY
Brief Summary: The purpose of this study is to identify the dose(s) of IDEA-033 that will provide a meaningful effect for treating osteoarthritis of the knee.
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Jun 2005
Primary Completion Date: No data available
Completion Date: No data available

Study Record Dates

First Submitted: Sep 13, 2005
First Submitted that Met QC Criteria: Sep 13, 2005
First Posted: Sep 21, 2005Estimated
Last Update Submitted that Met QC Criteria: Mar 19, 2009
Last Update Posted: Mar 20, 2009Estimated
Last Verified: Mar 2009

NCT00265304Completed

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

NCT00316784Completed

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

NCT01557816Unknown status

Trial of Naproxen to Evaluate Various Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee

NCT00447486Completed

A Study of GW842166 in Adults With Osteoarthritis Pain

NCT01207115Completed

A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee

NCT00240773Completed

A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee